NewsRx

Search our medical news database

Avitar, Inc.

Companies offered risk assessment tool focused on workplace drug abuse

Published in Medical Device Business Week, February 9th, 2005

Avitar, Inc., (AVR), the company that developed the world's first on-site oral test for drugs-of-abuse, announced the availability of the Drug-Free Workplace Profile, a self-audit risk assessment tool that helps corporations review and gain better insight into the issues and problems associated with developing and implementing a drug-free workplace policy.

"Ten percent of the U.S. workforce abuses drugs which costs employers more than $110B every year," shares Peter Phildius, chairman and CEO of Avitar.

"Companies that lack corporate drug testing programs suffer repercussions in cost and safety including: higher employee turnover and absenteeism,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook